ABIVAX to present at the Biotech Showcase™ Annual Conference in San Francisco

Paris, January 4th, 2017 - ABIVAX (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral disease, today announced that Prof. Hartmut Ehrlich, M.D., CEO of ABIVAX, will present at the Biotech Showcase™ Annual Conference to be held in San Francisco (CA, United States) on January 9 – 11, 2017 at the Hilton San Francisco Union Square Hotel.
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.

Prof. Hartmut Ehrlich will present at the Biotech Showcase™ as follows:


Date: Tuesday, January 10, 2017
Time: 10:00 am (PST)
Track: Room 7 (Ball room)
Venue: Hilton San Francisco Union Square Hotel
333 O’Farrell Street, San Francisco, CA (United States)

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41